Pricey peaches from Fukushima nuclear disaster zone on offer at Harrods, U.K.'s poshest department store
London luxury hotspot Harrods says it proudly sells "the most exquisite products from around the world" - including some ...
I ate a £27 peach from Fukushima so you don’t have to
It was mere seconds after I entered the gilded halls of Harrods’ food court in search of the most expensive fruit I will ever ...
ENDPOINTS NEWS2d
Mer­ck and Dai­ichi’s re­ject­ed HER3 ADC clears a Phase 3 in cer­tain lung can­cers
Merck and Daiichi Sankyo have passed a Phase 3 with the lead antibody-drug conjugate from the megadeal they disclosed at last ...
Daiichi Sankyo-Merck's 'guided-missile' cancer drug meets main goal in late-stage trial
Daiichi Sankyo and Merck said on Tuesday that their drug, patritumab deruxtecan, met the main goal of extending the time some ...
FierceBiotech10d
Merck, Daiichi repeat early success in small cell lung cancer with updated ADC data
Merck & Co.’s long-running effort to land a punch on small cell lung cancer (SCLC) has racked up a small victory. | Merck & ...
Astra, Daiichi Drop on Mixed Lung Cancer Drug Trial Result
Daiichi Sankyo Co. shares drop as much as 10.4% on Tuesday, the most since Aug. 5, after its lung cancer drug with ...
FierceBiotech9d
AstraZeneca, Daiichi unpack Dato-DXd's overall survival fail ahead of FDA decision
AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has failed to improve overall survival (OS) in ...
FiercePharma6d
ESMO: AZ, Daiichi build case for Enhertu in breast cancer patients with brain metastases
Daiichi Sankyo and AstraZeneca are padding the case for their antibody-drug conjugate Enhertu with new data demonstrating the ...
Merck & Daiichi Sankyo's Ifinatamab Deruxtecan Shows Promising Results In Phase 2 Lung Cancer Trial
(RTTNews) - Merck & Co., Inc. (MRK) and Daiichi Sankyo (DSKYF.PK) announced that an interim analysis of the dose-optimization phase of the ongoing IDeate-Lung01 Phase 2 trial shows ifinatamab ...